| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
CRK |
CRK: Proto-oncogene C-crk |
0.535 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
0.535 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
EPHA3 |
EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor |
0.535 |
Evidence |
|
| SLC9A1 |
SLC9A1, APNH1, NHE1: Sodium/hydrogen exchanger 1 |
SCAMP1 |
SCAMP1, SCAMP: Secretory carrier-associated membrane protein 1 |
0.535 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.535 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHA3 |
EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor |
0.535 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
0.535 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
CRK |
CRK: Proto-oncogene C-crk |
0.535 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
IGHE |
IGHE: Ig epsilon chain C region |
0.535 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
IGHG1 |
IPI00645627 |
0.535 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
IGHA2 |
IGHA2: Ig alpha-2 chain C region |
0.535 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
IGHD |
IPI00549398 |
0.535 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
IGHM |
IPI00645352 |
0.535 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
HLA-A |
IPI00719058 |
0.535 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
PTPNS1 |
SIRPA, BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP: Tyrosine-protein phosphatase non-rec |
0.535 |
Evidence |
|
| NPR3 |
IPI00013826 |
NPPC |
NPPC, CNP2: C-type natriuretic peptide precursor [Contains: CNP-22; CNP-29; CNP- |
0.535 |
Evidence |
|
| GJA1 |
GJA1, GJAL: Gap junction alpha-1 protein |
TJP2 |
TJP2, X104, ZO2: Tight junction protein ZO-2 |
0.535 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.535 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.535 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
0.535 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.535 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.535 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.535 |
Evidence |
|